Record Information
Version1.0
Creation Date2019-07-14 16:37:07 UTC
Last Updated2019-10-01 21:41:32 UTC
CypComp IDCC02152
Compound Information
NameThalidomide
Structure ImageUejjhqnacjxskw vifpvbqesa n
InChIKeyUEJJHQNACJXSKW-VIFPVBQESA-N
PubChem ID92142
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <14,H;Hydroxylation;R1>
  • <15,H;Hydroxylation;R2>
  • Not Available
  • <2,H;Hydroxylation;R1>
  • Not Available
  • <14,H;Hydroxylation;R1>
  • <15,H;Hydroxylation;R2>
  • <13,H;Hydroxylation;R3>
  • <14,H;Hydroxylation;R3>
  • <15,H;Hydroxylation;R4>
  • <16,H;Hydroxylation;R4>
  • <14,H;Hydroxylation;R1>
  • <15,H;Hydroxylation;R2>
  • <13,H;Hydroxylation;R3>
  • <14,H;Hydroxylation;R3>
  • <15,H;Hydroxylation;R4>
  • <16,H;Hydroxylation;R4>
  • <2,H;Hydroxylation;R5>
  • Not Available
  • <14,H;Hydroxylation;R1>
  • <15,H;Hydroxylation;R2>
  • Not Available
References
  1. Ando Y, Fuse E, Figg WD: Thalidomide metabolism by the CYP2C subfamily. Clin Cancer Res. 2002 Jun;8(6):1964-73. [PubMed:12060642 ]
Download FileCC02152.sdf